Immunogenicity of therapeutic antibodies
Monoclonal antibody therapy has revolutionised the treatment of many diseases, including chronic inflammatory diseases and cancer. Antibody therapy can unfortunately also elicit an unwanted immune response, leading to anti-drug antibodies (ADA). Karin van Schie provides a detailed characterization of the ADA response and its associated immune complex formation, to better understand the causes and mechanisms behind the adverse clinical observations.
K.A.J. van Schie: Immunogenicity of Therapeutic Antibodies: Immunological Mechanisms & Clinical Consequences.
Prof. S.M. van Ham
Dr T. Rispens (Sanquin Research)
Dr G.J. Wolbink (Reade)
Oudezijds Voorburgwal 229 - 231 | 1012 EZ AmsterdamGo to detailpage
+31 (0)20 525 2362
This event is open to the public.